It has been posited that adiposity may affect adenocarcinoma risk through other pathways, such as inflammation or insulin-like growth factor 1 (IGF1),33–35 but direct evidence for such mechanisms remains limited. This evidence concerns the gene IGF1 and adenocarcinoma.